下载

National Institute for Biological Standards and Control

2. 负责的公营或私营组织或公司
The Medicines and Healthcare products Regulatory Agency, a Non-Departmental Public Body of the UK Department of Health & Social Care
3. 地点和通信地址
Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG
4. 所报活动的资金来源,包括说明国防部是否为活动提供全部资金或部分资金

UK Government (Department for Health and Social Care; Home Office)

5. 研究中心和/或实验室内的最高封闭性单元5 数目,说明各单元的大小(平方米)
BL 4 , 59.00 平方米
BL 4 , 59.00 平方米
6. 活动的范围和概况,包括酌情填明有关微生物和/或毒素的类型

In general, the activities are related to development of assays and testing of reagents. During 2020 active projects involving the following organisms and/or toxinswere undertaken:

Highly pathogenic influenza virus – reagent development for highly pathogenic avian influenza (HPAI) viruses (H5Nx, H7N9) and associated research.

Bacillus anthracis toxins – made available for vaccine testing, reagent development, development of in vitro assays to detect anthrax toxin neutralising antibodies.

Botulinum toxins (serotypes A, B, E) - laboratory testing of therapeutic toxins; development of cell-based assays for clostridial toxins.

 

(4) 对于参加国家生物战防御研究与发展方案的、有最高封闭性单元的设施,请填明设施名称并注明“根据表格A第2 (三)部分宣布”。

(5) 根据1983年世界卫生组织《实验室生物安全手册》或同等标准。